GENEVA, July 27 -- SYSTIMMUNE, INC. filed a patent application (US2026/011318) for “ANTI-BCMA ANTIBODY AND METHOD OF MAKING AND USING THEREOF”. With publication no. WO/2026/156098, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 16/28

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....